Abbott Laboratories (NYSE: ABT) director receives 432 stock equivalent units as deferred fees
Abbott Laboratories (NYSE: ABT) director receives 432 stock equivalent units as deferred fees Stock Titan
Abbott Laboratories (NYSE: ABT) director receives 432 stock equivalent units as deferred fees Stock Titan
Summary aggregated from Stock Titan's public RSS feed. The full reporting belongs to Stock Titan — please read it on their site.